Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details)

v3.22.1
SIGNIFICANT ACCOUNTING POLICIES, Revenue Recognition (Details)
12 Months Ended
Dec. 31, 2021
Biotest License Agreement [Member]  
Revenue Recognition [Abstract]  
Amortization period 22 years